Effect of enzalutamide on health-related quality of life (HRQoL) in men with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel-based therapy: Results from the AFFIRM study Meeting Abstract


Authors: Miller, K.; Scher, H. I.; Fizazi, K.; Basch, E. M.; Sternberg, C. N.; Hirmand, M.; Cella, D.; Ivanescu, C.; Phung, D.; Spalding, J. R.; Bui, C. N.; Holmstrom, S.; De Bono, J. S.
Abstract Title: Effect of enzalutamide on health-related quality of life (HRQoL) in men with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel-based therapy: Results from the AFFIRM study
Meeting Title: 2013 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 6 Suppl.
Meeting Dates: 2013 Feb 14-16
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-02-20
Language: English
ACCESSION: WOS:000333679600020
DOI: 10.1200/jco.2013.31.6_suppl.17
PROVIDER: wos
Notes: Meeting Abstract: 17 -- Source: Wos
Altmetric Score
MSK Authors
  1. Ethan Martin Basch
    152 Basch
  2. Howard Scher
    792 Scher